AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR-CHK2 interaction and prostate cancer survival

Huy Q Ta1, Natalia Dworak1, Melissa L Ivey1

  • 1Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, United States.

Elife
|June 25, 2020
PubMed

Insights

Checkpoint kinase 2 (CHK2) directly binds androgen receptor (AR), suppressing prostate cancer growth. DNA damage enhances this interaction, but CHK2 mutations disrupt it, promoting cancer cell survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Checkpoint kinase 2 (CHK2) is a known negative regulator of androgen receptor (AR) transcriptional activity, prostate cancer (PCa) cell growth, and androgen sensitivity.
  • Previous studies established CHK2's role in regulating AR and PCa progression.

Purpose of the Study:

  • To investigate the direct interaction between AR and CHK2.
  • To elucidate the role of ionizing radiation (IR) in modulating AR-CHK2 interactions.
  • To determine the impact of CHK2 kinase activity and mutations on AR regulation and PCa cell growth.

Main Methods:

  • Co-immunoprecipitation assays to detect AR-CHK2 interactions.
  • Analysis of AR phosphorylation and CHK2 kinase activity.
  • Assessment of CHK2 mutant effects on AR-CHK2 binding and cell growth.
  • Evaluation of CHK2 depletion effects on DNA repair genes and cell survival.

Main Results:

  • AR directly interacts with CHK2, and this interaction is significantly increased by ionizing radiation (IR).
  • IR-induced AR-CHK2 interaction enhancement is dependent on AR phosphorylation and CHK2 kinase activity.
  • Prostate cancer-associated CHK2 mutants with reduced kinase activity show diminished IR-induced AR-CHK2 interactions, leading to impaired negative regulation of cell growth.
  • CHK2 depletion results in increased transcription of DNA repair genes (DNAPK, RAD54), enhanced clonogenic survival, and accelerated resolution of DNA double-strand breaks.

Conclusions:

  • CHK2 acts as a negative regulator of AR transcriptional activity and PCa cell proliferation by directly sequestering AR.
  • Disruption of AR-CHK2 interaction, through CHK2 mutation or loss of expression, leads to increased AR transcriptional activity and promotes cancer cell survival, particularly in response to DNA damage.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.4K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.6K